Ryan Allway August 10th, 2022 News, Top News ARDS-003 is a novel therapeutic for acute systemic inflammation and prevention of acute respiratory distress syndrome (ARDS). ARDS-003 may offer steroid-sparing opportunities. ARDS-003 has demonstrated antiviral properties. ARDS-003 developed as an oral formulation for an immediate release administration. OTTAWA, ON, Aug. 10,... Read more